Medical Marijuana, Inc. owns 100% of HempMeds® Brasil
HempMeds® Brasil became the first company to offer legal medical cannabis products to Brazil when their products were approved by the country for import by those suffering from specific medical conditions. Through concentrated effort in supporting, educating, and organizing families in need, HempMeds® Brasil has been instrumental in creating access to medical cannabis in Brazil, a country of over 200 million people and the world’s ninth largest economy.
In 2014, Real Scientific Hemp Oil™ (RSHO™) became the first cannabis product to be legally imported into Latin America when Brazil approved its use for its citizens. RSHO™ is a prescription medication in the country, and purchases by approved patients in Brazil are fully subsidized by the government.
HempMeds® Brasil now works with thousands of families in need of legal cannabis to help them legally get access to Real Scientific Hemp Oil™. The company is also working hard to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO™ easier.
Prior to the summer of 2014, the government of Brazil viewed all cannabis products, including non-psychoactive hemp, as an illegal, controlled substance. However, this changed with the family of a little girl, Anny Fischer, who was suffering from a rare form of genetic epilepsy called CDKL5. Desperate for an alternative, her parents discovered the story of a Harper Howard, a girl in the US who was also suffering from CDKL5 epilepsy who found relief through RSHO™ CBD hemp oil.
After an expedited legal hearing, ANVISA, the federal health authority of Brazil, granted the Fischer family the first import authorization for RSHO™. This was the tipping point, and after a series of historic rulings to follow, ANVISA removed cannabidiol (CBD) entirely from Brazil’s prohibited substance use list and then suspended the import tax on it.
RSHO™ continued to break down barriers, as it was legally imported into the country as a prescription medication for a growing lineup of medical indications, adding Alzheimer’s disease, Parkinson’s disease, chronic pain, and migraines to the list with epilepsy.
Patients in Brazil interested in accessing RSHO™ should contact HempMeds® Brasil or call (21) 4063 9179.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.
* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.